Gynecology
News
Drugs
Xagena Medicine
Xagena.net
2011 - Risk of ovarian cancinoma in women with a pelvic mass: blood test for proteins HE4 and CA125 with ROMA algorithm
Fablyn reduces breast carcinoma risk in postmenopausal osteoporotic women
WHI 11-year follow-up: hormone therapy increases invasive breast cancer and mortality
Risk of mood disorders in partners of breast cancer patients
Increased risk of breast cancer associated with breast density
Blood pressure control in the treatment of pre-eclampsia
Metabolic markers to predict the risk of preeclampsia: 14 metabolites in early pregnancy identified
Pregnancy: thyroid and parathyroid surgery outcomes may be worse
Breast cancer: compliance in the TEAM trial
Reduced thyroid function linked to preeclampsia
Mortality rates reduced among children whose mothers received Iron and Folic acid supplements
Patients with early stage, HER2-positive breast cancer are at significant risk of recurrence
Triple drug combination for metastatic HER2+ breast cancer seems to be effective
Increased risk of death from non-small-cell lung cancer with hormone replacement therapy
Women with BRCA gene mutation diagnosed earlier with breast carcinoma
Higher residual estrogen levels following menopause may impact risk of joint pain
Nolvadex, Evista, and Livial reduce the risks of breast cancer but cause serious adverse events
Increased risk of recurrence of breast tumor with Livial
Breastfeeding reduces risk of breast tumor
Mifepristone prevents regrowth of ovarian cancer cells that survive chemotherapy
Postmenopausal women: aromatase inhibitors are more effective in preventing breast cancer than Tamoxifen
Breast cancer: change in HER2 status after treatment with Trastuzumab
Postmenopausal women: risks of long-term combination hormone therapy outweigh benefits
Pregnancy alone is not linked to increased risk for mental disorders
Hysterectomy: no evidence that removing the ovaries provides any additional benefit
Lower risk of breast cancer linked to migraine
Benefit of surgical removal of the ovaries differs between women with BRCA1 and BRCA2 mutations
Kidney transplant: Mycophenolate mofetil linked to specific birth defect pattern
Risk of ovarian cancer may be reduced by low fat diet
Pregnant women: routine thyroid screening should be limited to women with symptoms or history of thyroid disease
Next Pages [
1
]
2
3
4
5
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Psychiatry
•
Pulmonology
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions